# PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND

> **NCT06144736** · PHASE2 · RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 60 (estimated)

## Conditions studied

- Seminoma

## Interventions

- **PROCEDURE:** Robot-assisted retroperitoneal lymph node dissection
- **DRUG:** Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin

## Key facts

- **NCT ID:** NCT06144736
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-28
- **Primary completion:** 2026-08-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06144736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06144736, "PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06144736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*